Ontology highlight
ABSTRACT:
SUBMITTER: Eby C
PROVIDER: S-EPMC4407810 | biostudies-literature | 2012 Oct
REPOSITORIES: biostudies-literature
Seminars in thrombosis and hemostasis 20121009 7
After a decade of clinical investigation, pharmacogenetic-guided initial dosing of warfarin is at a crossroads. Genotypes for two single nucleotide polymorphisms (SNPs) in the cytochrome P 450 2C9 gene, affecting warfarin metabolism, and one SNP in vitamin K reductase complex 1 gene, affecting warfarin sensitivity, account for approximately 30% of therapeutic warfarin dosing variability in whites and Asians. Incorporating this genetic information, along with patient's age, body size, and other c ...[more]